COVAX | VSIAX | COVAX / VSIAX | |
Total Expense Ratio | 1.21 | 0.07 | 1,729% |
Annual Report Gross Expense Ratio | 1.36 | 0.07 | 1,943% |
Fund Existence | 23 years | 14 years | - |
Gain YTD | 2.227 | 6.566 | 34% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 894M | 59.2B | 2% |
Annual Yield % from dividends | 1.12 | 1.97 | 57% |
Returns for 1 year | -3.70 | 11.67 | -32% |
Returns for 3 years | -9.96 | 30.54 | -33% |
Returns for 5 years | 18.76 | 88.53 | 21% |
Returns for 10 years | -11.29 | 118.45 | -10% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NAIL | 96.92 | 1.07 | +1.12% |
Direxion Daily Hmbldrs&Supls Bull 3X ETF | |||
BKCI | 51.44 | 0.41 | +0.81% |
BNY Mellon Concentrated Internatnl ETF | |||
IWO | 312.06 | 1.23 | +0.40% |
iShares Russell 2000 Growth ETF | |||
PBOC | 28.39 | N/A | N/A |
PGIM S&P 500 Buffer 20 ETF - Oct | |||
THTA | 15.14 | -0.01 | -0.09% |
SoFi Enhanced Yield ETF |